Evidence map›Paper›PMID 39163273›Full record

ArticleGut microbes

Quercetin activates energy expenditure to combat metabolic syndrome through modulating gut microbiota-bile acids crosstalk in mice.

Xiaoqiang Zhu, Xiaojuan Dai, Lijun Zhao, Jing Li, Yanhong Zhu, Wenjuan He, Xinlei Guan, Tao Wu, Li Liu, Hongping Song and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Food-grade TiOJournal of nanobiotechnology · 2026
    Article
  2. Article
  3. Review
  4. Effects ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Frontiers in pharmacology · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xiaoqiang ZhuCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.ORCID 0009-0002-7823-415X
Xiaojuan DaiDepartment of Gastroenterology, Wuhan Fourth Hospital, Wuhan, China.
Lijun ZhaoNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Jing LiPharmaceutical Department, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yanhong ZhuNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Wenjuan HeCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Xinlei GuanCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Tao WuCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.
Li LiuDepartment of Pharmacy, Wuhan Fourth Hospital, Wuhan, China.
Hongping SongDepartment of Pharmacy, Wuhan Fourth Hospital, Wuhan, China.
Liang LeiCentral Laboratory, Wuhan Fourth Hospital, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abdominal obesity-related metabolic syndrome (MetS) has emerged as a significant global public health issue that affects human health. Flavonoids, such as quercetin, have been reported to exert obvious anti-obesity and lipid-lowering effects in both humans and animal models. However, the precise underlying mechanism remains elusive. In this study, we investigated the potential roles of gut microbiota-bile acids (BAs) interactions in quercetin-induced anti-obesity effects and metabolic benefits. Oral administration of quercetin significantly enhanced energy metabolism through activating thermogenesis of brown adipose tissues (BAT) and browning of white adipose tissues (WAT), thus mitigating metabolic dysfunctions in an abdominal obesity-related MetS mouse model. Further mechanistic studies demonstrated that quercetin treatment substantially promoted the generation of non-12α-hydroxylated BAs (non-12OH BAs), particularly ursodeoxycholic acid (UDCA) and lithocholic acid (LCA), in serum via regulating the overall structure of gut microbiota and enriching

Indexed as

Adipose Tissue, BrownBile Acids and SaltsEnergy MetabolismGastrointestinal MicrobiomeMetabolic SyndromeMice, Inbred C57BLQuercetinThermogenesisAdipose Tissue, WhiteAnimalsDisease Models, AnimalFecal Microbiota TransplantationMaleMiceReceptors, G-Protein-CoupledBile Acids and SaltsGpbar1 protein, mouseQuercetinReceptors, G-Protein-Coupledbile acidsenergy metabolismgut microbiotametabolic syndromeQuercetin

Identifiers

PMID39163273
PMCPMC11340765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.